Partial Deletion of the Nicotinic Cholinergic Receptor α4 or β2 Subunit Genes Changes the Acetylcholine Sensitivity of Receptor-Mediated 86Rb+ Efflux in Cortex and Thalamus and Alters Relative Expression of α4 and β2 Subunits
Authors:
- Milena MorettiMMMilena Moretti
- Natalie M. MeinerzNMNatalie M. Meinerz
- Francesco ClementiFCFrancesco Clementi
- Annalisa GaimarriAGAnnalisa Gaimarri
- Allan C. CollinsACAllan C. Collins
- Michael J. MarksMMMichael J. Marks
- 1 June 2008
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 73 (6) , 1796-1807
Abstract
α4 and β2 nicotinic cholinergic receptor (nAChR) subunits can assemble in heterologous expression systems as pentameric receptors with different subunit stoichiometries that exhibit differential sensitivity to activation by acetylcholine, yielding biphasic concentration-effect curves. nAChR-mediated 86Rb+ efflux in mouse brain synaptosomes also displays biphasic acetylcholine (ACh) concentration-response curves. Both phases are mediated primarily by α4β2*-nAChR, because deletion of either the α4 or β2 subunit reduces response at least 90%. A relatively larger decrease in the component of 86Rb+ efflux with lower ACh sensitivity occurred with partial deletion of α4 (α4+/-), whereas a larger decrease in the component with higher ACh sensitivity was elicited by partial deletion of β2 (β2+/-). Immunoprecipitation with selective antibodies demonstrated that more than 70% of [3H]epibatidine binding sites in both regions contained only α4 and β2 subunits. Subsequently, α4 and β2 subunit content in the cortex and thalamus of α4 and β2 wild types and heterozygotes was analyzed with Western blots. Partial deletion of α4 decreased and partial deletion of β2 increased the relative proportion of the α4 subunit in assembled receptors. Although these methods do not allow exact identification of stoichiometry of the subtypes present in wild-type cortex and thalamus, they do demonstrate that cortical and thalamic nAChRs of the α4+/- and β2+/- genotypes differ in relative expression of α4 and β2 subunits a result that corresponds to the relative functional changes observed after partial gene deletion. These results strongly suggest that α4β2-nAChR with different stoichiometry are expressed in native tissue.Keywords
This publication has 42 references indexed in Scilit:
- Gene targeting demonstrates that α4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholineNeuropharmacology, 2007
- Ca2+ Permeability of the (α4)3(β2)2 Stoichiometry Greatly Exceeds That of (α4)2(β2)3 Human Acetylcholine ReceptorsMolecular Pharmacology, 2007
- Immunolabeling demonstrates the interdependence of mouse brain α4 and β2 nicotinic acetylcholine receptor subunit expressionJournal of Comparative Neurology, 2006
- Deletion of the α7, β2, or β4 Nicotinic Receptor Subunit Genes Identifies Highly Expressed Subtypes with Relatively Low Affinity for [3H]EpibatidineMolecular Pharmacology, 2006
- Brain nicotinic acetylcholine receptors: native subtypes and their relevanceTrends in Pharmacological Sciences, 2006
- Untranslated Region-Dependent Exclusive Expression of High-Sensitivity Subforms of α4β2 and α3β2 Nicotinic Acetylcholine ReceptorsMolecular Pharmacology, 2006
- Expression of Nigrostriatal α6-Containing Nicotinic Acetylcholine Receptors Is Selectively Reduced, but Not Eliminated, by β3 Subunit Gene DeletionMolecular Pharmacology, 2005
- Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatmentNeuropharmacology, 2004
- Subunit Composition and Pharmacology of Two Classes of Striatal Presynaptic Nicotinic Acetylcholine Receptors Mediating Dopamine Release in MiceMolecular Pharmacology, 2004
- Alternate Stoichiometries of α4β2 Nicotinic Acetylcholine ReceptorsMolecular Pharmacology, 2003